214.74 USD
↘ 0.66 (0.31%)PRE MARKET (AS OF 08:15 AM EDT)
Open?$215.67
High?$215.67
Low?$213.83
Prev. Close?$215.40
Volume?2.4K
Avg. Volume?6.2M
VWAP?$215.33
Rel. Volume?0.00x
Bid / Ask
Bid?$214.90 × 200
Ask?$215.60 × 100
Spread?$0.70
Midpoint?$215.25
Valuation & Ratios
Market Cap?380.6B
Shares Out?1.8B
Float?1.8B
Float %?100.0%
P/E Ratio?105.57
P/B Ratio?-57.18
EPS?$2.04
Dividend?3.11%
Ex-Dividend?N/A
Shares of ABBVIE INC. (ABBV) are trading at $214.74. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place ABBV at a fair price relative to peers.
Technical & fundamental data as of Jun 2, 2026.
News
Profile
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Themes
Employees
57.0K
Market Cap
376.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-12-10
Address
1 NORTH WAUKEGAN ROAD
NORTH CHICAGO, IL 60064
Phone: (847) 932-7900
NORTH CHICAGO, IL 60064
Phone: (847) 932-7900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?41
Momentum?38
Short Sent.?73
Piotroski F-Score?6/9Mixed
Altman Z-Score?2.16Grey
Confidence?74%Moderate
Short InterestModerate
Short % of Float?1.28%Low
Short Interest?22.6M
Days to Cover?4.0
Free Float1.8B
Avg Daily Volume5.7M
Settlement Date2026-05-15
Financial Health
Current Ratio?0.80Weak
Quick Ratio?0.68Weak
Cash Ratio?0.22Low
Debt/Equity?-10.95Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score67/100
P/E?105.6PRICEY▾
Peers20
S&P3
P/B?-57.18CHEAP▾
Peers100
S&P97
P/S?6.06FAIR▾
Peers36
S&P22
P/FCF?17.7CHEAP▾
Peers67
S&P64
EV/EBITDA?15.5FAIR▾
Peers60
S&P47
EV/Sales?7.07HIGH▾
Peers36
S&P20
Returns & Efficiency
ROE?-54.2%WEAK▾
Peers10
S&P3
ROA?2.6%WEAK▾
Peers20
S&P25
Cash Flow & Enterprise
FCF?$21.5B
Enterprise Value?$444.0B
Fundamentals ratios updated end of day